Pharmaceutical
Manufacturing
Health
Cardinal Health
$47.799876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$47.79
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.23 (0.48%) Today
$0.00 (0.00%) After Hours
Why Robinhood?
You can buy or sell CAH and other stocks, options, ETFs, and crypto commission-free!
About
Cardinal Health, Inc. engages in the provision of pharmaceutical and medical products. It operates through the Pharmaceutical and Medical segments. Read More The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products in the United States. The Medical segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. The company was founded by Robert D. Walter in 1971 and is headquartered in Dublin, OH.
Employees
50,200
Headquarters
Dublin, Ohio
Founded
1971
Market Cap
14.17B
Price-Earnings Ratio
—
Dividend Yield
3.82
Average Volume
3.45M
High Today
$48.53
Low Today
$47.53
Open Price
$48.06
Volume
1.11M
52 Week High
$66.45
52 Week Low
$42.17
Collections
Pharmaceutical
Manufacturing
Health
Business Services
Medical
Healthcare
Consumer Products
Pharmacies
News
Washington Post3h
Vermont sues 2 prescription opioid distributors
BURLINGTON, Vt. — Vermont filed a lawsuit Tuesday against two pharmaceutical distributors, accusing them of selling ever-increasing amounts of prescription opioids in the state while failing to effectively monitor and control the sales and acknowledge the quantity of pills was outpacing the need.
Price Paid on Robinhood
10% Lower
Right Now
52 Week Low
$42.17
Average Price Paid
$53.23
52 Week High
$66.45
Earnings
$0.93
$1.13
$1.32
$1.52
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
—
Actual
Expected May 2, Pre-Market